Plasma homocysteine and calcific aortic valve disease
Authors:
Open Access
Abstract
We retrospectively analysed 76 patients with a mean (SD) age of 66 (13) years, (65% male) who underwent cardiac surgery at the Cleveland Clinic Foundation with intraoperative transoesophageal echocardiography. The patients were originally recruited for a prospective study assessing the relation between plasma homocysteine and aortic atheroma. Exclusion criteria were chronic renal failure, rheumatic heart disease, and known malignancy. All subjects gave informed consent and our institutional review board approved the study. All patients had fasting plasma homocysteine concentrations obtained on the day of their preoperative evaluation or on the morning of surgery. Venous blood was placed into a heparinised tube on ice, centrifuged within 10 minutes of blood being drawn, and analysed using a microparticle enzyme immunoassay. Normal plasma homocysteine ranges in our laboratory are 6.4–13.7 μmol/l for men and 3.4–12.9 μmol/l for women.Keywords
This publication has 5 references indexed in Scilit:
- Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valveThe American Journal of Cardiology, 2001
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJACC, 1997
- Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.Circulation, 1994
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.1969